Angela Walsh
2022
In 2022, Angela Walsh earned a total compensation of $426.8K as Senior Vice President of Finance at Virios Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $36,353 |
|---|---|
| Option Awards | $145,532 |
| Salary | $242,351 |
| Other | $2,580 |
| Total | $426,816 |
Walsh received $242.4K in salary, accounting for 57% of the total pay in 2022.
Walsh also received $36.4K in non-equity incentive plan, $145.5K in option awards and $2.6K in other compensation.
Rankings
In 2022, Angela Walsh's compensation ranked 4,543rd out of 5,625 executives tracked by ExecPay. In other words, Walsh earned more than 19.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,543 out of 5,625 | 19th |
Division Manufacturing | 2,534 out of 3,053 | 17th |
Major group Chemicals And Allied Products | 1,207 out of 1,380 | 13th |
Industry group Drugs | 1,133 out of 1,281 | 12th |
Industry Pharmaceutical Preparations | 819 out of 927 | 12th |
Source: SEC filing on April 27, 2023.
Walsh's colleagues
We found two more compensation records of executives who worked with Angela Walsh at Virios Therapeutics in 2022.
News
Virios Therapeutics CEO Greg Duncan's 2023 pay falls 39% to $567K
April 25, 2024
Virios Therapeutics CEO Greg Duncan's 2022 pay slips 15% to $937K
April 27, 2023
Virios Therapeutics CEO Greg Duncan's 2021 pay falls 69% to $1.1M
April 26, 2022
Virios Therapeutics CEO Greg Duncan receives $3.5M in 2020
April 28, 2021